Neeraj Sharma, CEO & MD, OneSource Specialty Pharma Limited speaking on the development said "We are extremely excited to secure SFDA approval for semaglutide in Saudi Arabia, one of the largest GLP-1 market globally with significant long-term potential
Research reviews describe BPC-157 as being studied across muscle, tendon, ligament, bone and gastrointestinal tissue models, with discussion around angiogenesis, collagen synthesis, fibroblast activity and nitric oxide pathway modulation
This assessment is supported by a report of a prefusion-stabilized version of the HCMV gB ectodomain used to immunize mice: notably, the stabilized construct did not produce superior neutralization titres compared with a non-stabilized postfusion construct, whereas general complement-independent elicitation of neutralizing antibodies was low 17
When I left Novo Nordisk in 2021, I was convinced GLP-1s would be transformative, but only if used alongside real lifestyle change